35th week of 2021 patent applcation highlights part 24 |
Patent application number | Title | Published |
20210269415 | HETEROARYL AZOLE COMPOUND AND PEST CONTROL AGENT | 2021-09-02 |
20210269416 | CHEMICAL PROCESS FOR PREPARING PHENYLPIPERIDINYL INDOLE DERIVATIVES | 2021-09-02 |
20210269417 | Kinase Inhibitors | 2021-09-02 |
20210269418 | HSP90 BETA SELECTIVE INHIBITORS | 2021-09-02 |
20210269419 | 1,2,4-TRIAZOLE DERIVATIVES AS TANKYRASE INHIBITORS | 2021-09-02 |
20210269420 | HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | 2021-09-02 |
20210269421 | WATER-SOLUBLE FLUORESCENT PROBE AND NANOPARTICALS WITH AGGREGATION-INDUCED EMISSION EFFECT FOR OVARIAN CANCER AND PREPARATION METHOD AND USE THEREOF | 2021-09-02 |
20210269422 | SOLID FORMS OF AN AZOLOPYRIMIDINE COMPOUND | 2021-09-02 |
20210269423 | PIPERAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE | 2021-09-02 |
20210269424 | PYRIMIDINE DERIVATIVE AND PREPARATION PROCESS AND USE THEREOF | 2021-09-02 |
20210269425 | CDK2 INHIBITORS | 2021-09-02 |
20210269426 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | 2021-09-02 |
20210269427 | Process For Preparing Aminopyrimidine Derivatives | 2021-09-02 |
20210269428 | SALT AND CRYSTAL FORMS OF PLK-4 INHIBITOR | 2021-09-02 |
20210269429 | N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl- )-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof | 2021-09-02 |
20210269430 | IMPROVED COMPOUNDS FOR MYC INHIBITION | 2021-09-02 |
20210269431 | SMALL MOLECULE PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) INHIBITORS AND METHODS OF TREATMENT | 2021-09-02 |
20210269432 | KRAS G12C INHIBITORS | 2021-09-02 |
20210269433 | BCL-2 INHIBITORS | 2021-09-02 |
20210269434 | TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS | 2021-09-02 |
20210269435 | NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS | 2021-09-02 |
20210269436 | JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE | 2021-09-02 |
20210269437 | CRYSTALLINE HYDRATE OF A JAK INHIBITOR COMPOUND | 2021-09-02 |
20210269438 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | 2021-09-02 |
20210269439 | PYRIDOPYRIMIDINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 2021-09-02 |
20210269440 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | 2021-09-02 |
20210269441 | Crystal form as ASK1 inhibitor and preparation method and application thereof | 2021-09-02 |
20210269442 | FUSED RING DERIVATIVE USED AS FGFR4 INHIBITOR | 2021-09-02 |
20210269443 | PHARMACEUTICALLY ACCEPTABLE SALTS OF SEPIAPTERIN | 2021-09-02 |
20210269444 | Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester | 2021-09-02 |
20210269445 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | 2021-09-02 |
20210269446 | FORMS OF A PI3K DELTA SELECTIVE INHIBITOR FOR USE IN PHARMACEUTICAL FORMULATIONS | 2021-09-02 |
20210269447 | NOVEL AMINO-IMIDAZOPYRIMIDINE DERIVATIVES AS JANUS KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF | 2021-09-02 |
20210269448 | ALKYNYL (HETERO) AROMATIC RING COMPOUNDS USED FOR INHIBITING PROTEIN KINASE ACTIVITY | 2021-09-02 |
20210269449 | SIDEROPHORE CONJUGATED PYRAZOLIDINONES, AND ANALOGUES THEREOF | 2021-09-02 |
20210269450 | IMPACT RESISTANT MATERIAL | 2021-09-02 |
20210269451 | PYRIDINYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE | 2021-09-02 |
20210269452 | ETHYNYL DERIVATIVES | 2021-09-02 |
20210269453 | Bryoid Compositions, Methods of Making and Use Thereof | 2021-09-02 |
20210269454 | CYCLOALKANE-1,3-DIAMINE DERIVATIVE | 2021-09-02 |
20210269455 | QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS | 2021-09-02 |
20210269456 | SUBSTITUTED MACROCYCLIC INDOLE DERIVATIVES | 2021-09-02 |
20210269457 | A PROCESS FOR PURIFICATION OF PROTECTED POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVES | 2021-09-02 |
20210269458 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | 2021-09-02 |
20210269459 | ISOTHIAZOLO[5,4-D]PYRIMIDINE COMPOUND AS IRAK4 INHIBITOR | 2021-09-02 |
20210269460 | RARE-EARTH COMPLEX, LIGHT-EMITTING MATERIAL, LIGHT-EMITTING OBJECT, LIGHT-EMITTING DEVICE, INTERLAYER FOR LAMINATED GLASS, LAMINATED GLASS, WINDSHIELD FOR VEHICLE, WAVELENGTH CONVERSION MATERIAL, AND SECURITY MATERIAL | 2021-09-02 |
20210269461 | AN INORGANIC APPROACH TO RENDERING METAL-ORGANIC FRAMEWORKS ELECTRICALLY CONDUCTIVE | 2021-09-02 |
20210269462 | METHODS OF MAKING MOFS, SYSTEMS FOR SYNTHESIZING MOFS, AND METHODS OF COATING TEXTILES WITH MOFS | 2021-09-02 |
20210269463 | SILICON PRECURSOR COMPOUND, PREPARATION METHOD THEREFOR, AND SILICON-CONTAINING FILM FORMATION METHOD USING SAME | 2021-09-02 |
20210269464 | POLYOXYALKYLENE COUPLED ZWITTERIONIC MOIETY AND SURFACE ACTIVE REACTIVE POLYMERS, COATING COMPOSITIONS AND FOULING CONTROL COATINGS THEREOF | 2021-09-02 |
20210269465 | METAL COMPLEX COMPRISING AMIDINE AND INDOLE FUSED CYCLOPENTADIENYL LIGANDS | 2021-09-02 |
20210269466 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2021-09-02 |
20210269467 | HYDROPHOBIC INTERACTION CHROMATOGRAPHY FOR PURIFICATION OF OLIGONUCLEOTIDES | 2021-09-02 |
20210269468 | USE OF UAP INHIBITORS TO INHIBIT FLUX THROUGH THE HEXOSAMINE BIOSYNTHETIC PATHWAY | 2021-09-02 |
20210269469 | TERPENE GLYCOSIDE DERIVATIVES AND USES THEREOF | 2021-09-02 |
20210269470 | SEGMENT FOR USE IN SYNTHESIS OF OLIGONUCLEOTIDE, METHOD FOR PRODUCING THE SAME, AND METHOD FOR SYNTHESIZING OLIGONUCLEOTIDE USING THE SAME | 2021-09-02 |
20210269471 | HYDRATE CRYSTAL OF 3',3'-cGAMP | 2021-09-02 |
20210269472 | Compounds and Methods for the Modulation of Proteins | 2021-09-02 |
20210269473 | TGR5 MODULATORS AND METHODS OF USE THEREOF | 2021-09-02 |
20210269474 | INTERMEDIATES FOR THE PREPARATION OF 11-METHYLENE STEROIDS | 2021-09-02 |
20210269475 | FARNESOID X RECEPTOR MODULATORS | 2021-09-02 |
20210269476 | SEPARATING AGENT | 2021-09-02 |
20210269477 | Methods and Systems for Processing a Cell Culture | 2021-09-02 |
20210269478 | ADJUVANT FOR CELL CULTURE | 2021-09-02 |
20210269479 | USE OF CYCLOSPORINE ANALOGUES FOR TREATING CANCER | 2021-09-02 |
20210269480 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 | 2021-09-02 |
20210269481 | PEPTIDE FOR REGULATING REACTIVITY TO SEROTONIN REUPTAKE INHIBITORBASED ANTIDEPRESSANT, AND USE THEREOF | 2021-09-02 |
20210269482 | PEPTOID-PEPTIDE MACROCYCLES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME | 2021-09-02 |
20210269483 | PEPTIDE COMPOUNDS | 2021-09-02 |
20210269484 | CRYSTALLINE FORM OF CYCLOSPORIN A, METHODS OF PREPARATION, AND METHODS FOR USE THEREOF | 2021-09-02 |
20210269485 | VESICLES FOR CHARACTERIZATION OF BOTULINUM NEUROTOXINS | 2021-09-02 |
20210269486 | CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS | 2021-09-02 |
20210269487 | RECOMBINANT AAV1, AAV5, AND AAV6 CAPSID MUTANTS AND USES THEREOF | 2021-09-02 |
20210269488 | RECOMBINANT ROTAVIRUS EXPRESSION SYSTEM AND RECOMBINANT ROTAVIRUSES | 2021-09-02 |
20210269489 | PRE-FUSION RSV F ANTIGENS | 2021-09-02 |
20210269490 | Materials and Methods for Inhibiting Flavivirus Infection | 2021-09-02 |
20210269491 | FLAGELLIN-BASED AGENTS AND USES INCLUDING EFFECTIVE VACCINATION | 2021-09-02 |
20210269492 | Proteins from Anaerobic Fungi and Uses Thereof | 2021-09-02 |
20210269493 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER CHARACTERIZED WITH PCSK9 EXPRESSION | 2021-09-02 |
20210269494 | METHODS FOR TREATING FATTY LIVER DISEASE | 2021-09-02 |
20210269495 | MODIFIED ACTIVIN A | 2021-09-02 |
20210269496 | TISSUE TARGETED IMMUNOTOLERANCE WITH A CD39 EFFECTOR | 2021-09-02 |
20210269497 | INTERLEUKIN-2 VARIANTS AND METHODS OF USES THEREOF | 2021-09-02 |
20210269498 | PARTIAL AGONISTS OF INTERLEUKIN-2 | 2021-09-02 |
20210269499 | HEPATITIS B AND/OR HEPATITIS D-PERMISSIVE CELLS AND ANIMALS | 2021-09-02 |
20210269500 | CELL SURFACE COUPLING OF NANOPARTICLES | 2021-09-02 |
20210269501 | COMPOSITIONS AND METHODS OF NKG2D CHIMERIC ANTIGEN RECEPTOR T CELLS FOR CONTROLLING TRIPLE-NEGATIVE BREAST CANCER | 2021-09-02 |
20210269502 | TUMOR-SPECIFIC IFNA SECRETION BY CAR T-CELLS TO REPROGRAM THE SOLID TUMOR MICROENVIRONMENT | 2021-09-02 |
20210269503 | PEPTIDE DEFICIENT-MHC CLASS I/CHAPERONE COMPOSITIONS AND METHODS | 2021-09-02 |
20210269504 | PROTEIN-BASED MICELLES FOR THE DELIVERY OF HYDROPHOBIC ACTIVE COMPOUNDS | 2021-09-02 |
20210269505 | TWEAK-receptor agonists for use in combination with immunotherapy of a cancer | 2021-09-02 |
20210269506 | POLYNUCLEOTIDES ENCODING IMMUNE MODULATING POLYPEPTIDES | 2021-09-02 |
20210269507 | NOVEL HUMAN SERUM ALBUMIN MUTANT | 2021-09-02 |
20210269508 | METHODS FOR REGULATING ENDOGENOUS PRODUCTION OF LACTOFERRIN AND SUB-PEPTIDES THEREOF | 2021-09-02 |
20210269509 | METHOD FOR PRODUCING A CONTROLLED MIXTURE OF TWO OR MORE DIFFERENT ANTIBODIES | 2021-09-02 |
20210269510 | ANTIBODIES HAVING SPECIFICITY FOR THE ORF2I PROTEIN OF HEPATITIS E VIRUS AND USES THEREOF FOR DIAGNOSTIC PURPOSES | 2021-09-02 |
20210269511 | ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOF | 2021-09-02 |
20210269512 | ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF | 2021-09-02 |
20210269513 | ENHANCED DELIVERY OF DRUGS TO THE BRAIN | 2021-09-02 |
20210269514 | IMMUNOGLOBULIN VARIABLE DOMAINS | 2021-09-02 |